Parkinson's disease and obsessive-compulsive spectrum;Enfermedad de Parkinson y espectro obsesivo-compulsivo

Revista de Neurologia

Volumn 49, Issue 4, 2009, Pages 202-209

  Lopez Morinigo J D ^a   Ramos Ríos, Ramón ^a,b   Martinez Formoso S ^a   Arrojo Romero, M ^a   Ecenarro Tome P ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b Hospital Gil Casares   (Spain)

Author keywords

Dopaminergic agonists; Impulse control disorders; Obsessive compulsive disorder; Obsessive compulsive symptoms; Parkinson's disease; Pathological gambling

Indexed keywords

CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; IMPULSE CONTROL DISORDER; MEDICAL RESEARCH; OBSESSIVE COMPULSIVE DISORDER; PARKINSON DISEASE; REVIEW;

EID: 70349234487     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4904.2008460     Document Type: Review

References (68)

1. Vallejo J. Teorías etiológicas. In Vallejo J, Berrios GE, eds. Estados obsesivos. Barcelona: Masson; 2006. p. 91-112.
2. Cornelio-Nieto JO. Neurobiología del síndrome de Tourette. Rev Neurol 2008; 46 (Supl 1): S21-3.
3. Rauch SL, Corá-Locatelli G, Greenberg BD. Patogenia del trastorno obsesivo-compulsivo. In Stein DJ, Hollander E, eds. Tratado de los trastornos de ansiedad. Barcelona: Psiquiatría Editores; 2004. p. 235-253
4. Saint-Cyr JA, Taylor AE, Nicholson K. Behavior and the basal ganglia. Adv Neurol 1995; 65: 1-28.
5. Martínez-González AE, Piqueras-Rodríguez JA. Actualización neuropsicológica del trastorno obsesivo-compulsivo. Rev Neurol 2008; 46: 618-625
6. Lochner C, Carey P, Seedat S, Stein DJ. Trastornos del espectro obsesivo-compulsivo. In Vallejo J, Berrios GE, eds. Estados obsesivos. Barcelona: Masson; 2006. p. 463-485
7. Zohar AH, Pauls DL, Ratzoni G, Apter A, Dycian A, Binder M, et al. Obsessive-compulsive disorder with and without tics in an epidemiological sample of adolescents. Am J Psychiatry 1997; 154: 274-276 (Pubitemid 27053740)
8. Lochner C, Stein DJ. Does work on obsessive-compulsive spectrum disorders contribute to understanding the heterogeneity of obsessive-compulsive disorder? Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 353-361
9. Noé-Sebastián E, Irimia-Sieira P, Pomares-Arias E, Martínez-Vila E, Luquin-Piudo MR. Trastornos neuropsiquiátricos en la enfermedad de Parkinson. Rev Neurol 2001; 32: 676-681
10. Voon V. Repetition, repetition, and repetition: compulsive and punding behaviors in Parkinson's disease. Mov Disord 2004; 19: 367-370 (Pubitemid 38559638)
11. Kulisevsky J, Linazasoro G, Luquin R, Valldeoriola F, Vela L. I Encuentro Nacional de Expertos en Enfermedad de Parkinson. Rev Neurol 2008; 46 (Supl 2): S5-53.
12. Stella F, Bucken-Gobbi LT, Gobbi S, Sant'Ana-Simões C. Síntomas depresivos y trastorno motor en pacientes con enfermedad de Parkinson. Rev Neurol 2007; 45: 594-598 (Pubitemid 350292876)
13. DeLong MR, Wichmann T. Circuits and circuit disorders of the basal ganglia. Arch Neurol 2007; 64: 20-24 (Pubitemid 46072419)
14. Alegret M, Junqué C, Valldeoriola F, Vendrell P, Martí MJ, Tolosa E. Obsessive-compulsive symptoms in Parkinson's disease. J Neurol Neurosurg Psychiatry 2001; 70: 394-396
15. Kurlan R. Disabling repetitive behaviors in Parkinson's disease. Mov Disord 2004; 19: 433-437 (Pubitemid 38559646)
16. Berrios GE. Trastorno obsesivo-compulsivo y enfermedad neurológica: estado actual de la cuestión. In Vallejo J, Berrios GE, eds. Estados obsesivos. Barcelona: Masson; 2006. p. 487-519.
17. Tomer R, Levin B, Weiner W. Obsessive-compulsive symptoms and motor asymmetries in Parkinson's disease. Neuropsychiatry Neuropsychol Behav Neurol 1993; 6: 26-30. (Pubitemid 23052995)
18. Müller N, Putz A, Kathmann N, Lehle R, Günther W, Straube A. Characteristics of obsessive-compulsive symptoms in Tourette's syndrome, obsessive-compulsive disorder, and Parkinson's disease. Psychiatry Res 1997; 70: 105-114 (Pubitemid 27245159)
19. Maia AF, Pinto AS, Barbosa ER, Menezes PR, Miguel EC. Obsessive-compulsive symptoms, obsessive-compulsive disorder, and related disorders in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2003; 15: 371-374 (Pubitemid 36999383)
20. Harbishettar V, Pal PK, Janardhan-Reddy YC, Thennarasu K. Is there a relationship between Parkinson's disease and obsessive-compulsive disorder? Parkinsonism Relat Disord 2005; 11: 85-88
21. Isaias IU, Siri C, Cilia R, De Gaspari D, Pezzoli G, Antonini A. The relationship between impulsivity and impulse control disorders in Parkinson's disease. Mov Disord 2008; 23: 411-415
22. Lees AJ. The neurobehavioural abnormalities in Parkinson's disease and their relationship to psychomotor retardation and obsessive-compulsive disorders. Behav Neurol 1989; 2: 1-11.
23. Sharma P, Gupta N. Obsessive-compulsive phenomenon and Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 72: 420-421
24. Hollander E, Cohen L, Richards M, Mullen L, DeCaria C, Stern Y. A pilot study of the neuropsychology of obsessive-compulsive disorder and Parkinson's disease: basal ganglia disorders. J Neuropsychiatry Clin Neurosci 1993; 5: 104-107 (Pubitemid 23073819)
25. Seijo-Zazo E, Seijo-Fernández F, Fernández-González F, Álvarez-Vega MA, Lozano-Aragoneses B. Propuesta de una nueva diana para la estimulación cerebral profunda en el trastorno obsesivo-compulsivo. Rev Neurol 2007; 45: 424-428 (Pubitemid 350292920)
26. Junqué C, Alegret M, Nobbe FA, Valldeoriola F, Pueyo R, Vendrell P, et al. Cognitive and behavioral changes after unilateral posteroventral pallidotomy: relationship with lesional data from MRI. Mov Disord 1999; 14: 780-789 (Pubitemid 29509620)
27. Mallet L, Mesnage V, Houeto JL, Pelissolo A, Yelnik J, Behar C, et al. Compulsions, Parkinson's disease, and stimulation. Lancet 2002; 360: 1302-1304
28. Hernán MA, Takkouche B, Caamaño-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002; 52: 276-284 (Pubitemid 35001493)
29. Evans AH, Lawrence AD, Potts J, MacGregor L, Katzenschlager R, Shaw K, et al. Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson's disease. J Neurol Neurosurg Psychiatry 2006; 77: 317-321 (Pubitemid 43295150)
30. Leiva-Santana C, Monge-Argilés JA, Galván-Berenguer B. Estudio de la personalidad en la enfermedad de Parkinson: influencia de factores motores y no motores. Rev Neurol 2007; 45: 7-12. (Pubitemid 350293003)
31. Glosser G, Clark C, Freundlich B, Kliner-Krenzel L, Flaherty P, Stern M. A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients. Mov Disord 1995; 10: 201-206
32. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993; 50: 975-990
33. Menza MA, Golbe LI, Cody RA, Forman NE. Dopamine-related personality traits in Parkinson's disease. Neurology 1993; 43: 505-508 (Pubitemid 23088482)
34. Myslobodsky M, Lalonde FM, Hicks L. Are patients with Parkinson's disease suicidal? J Geriatr Psychiatry Neurol 2001; 14: 120-124
35. Voon V, Kubu C, Krack P, Houeto JL, Tröster AI. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006; 21: S305-27. (Pubitemid 44028289)
36. American Psychiatric Association. Manual diagnóstico y estadístico de los trastornos mentales, 4 ed. Washington DC: APA; 1994.
37. Molina JA, Sainz-Artiga MJ, Fraile A, Jiménez-Jiménez FJ, Villanueva C, Ortí-Pareja M, et al. Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment? Mov Disord 2000; 15: 869-872
38. Seedat S, Kesler S, Niehaus DJ, Stein DJ. Pathological gambling behaviour: emergence secondary to treatment of Parkinson's disease with dopaminergic agents. Depress Anxiety 2000; 11: 185-186 (Pubitemid 30612771)
39. Driver-Dunckley E, Samanta J, Stacy M. Pathological gambling associated with dopamine agonist therapy in Parkinson's disease. Neurology 2003; 61: 422-423 (Pubitemid 36975988)
40. Dodd ML, Klos KJ, Bower JH, Geda YE, Josephs KA, Ahlskog JE. Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005; 62: 1377-1381
41. Voon V, Hassan K, Zurowski M, de Souza M, Thomsen T, Fox S, et al. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease. Neurology 2006;67:1254-1257 (Pubitemid 44563838)
42. Truong DD, Bhidayasiri R, Wolters E. Management of non-motor symptoms in advanced Parkinson disease. J Neurol Sci 2008; 266: 216-228 (Pubitemid 351186509)
43. Voon V, Fox SH. Medication-related impulse control and repetitive behaviors in Parkinson disease. Arch Neurol 2007; 64: 1089-1096 (Pubitemid 47258066)
44. Avanzi M, Baratti M, Cabrini S, Uber E, Brighetti G, Bonfà F. Prevalence of pathological gambling in patients with Parkinson's disease. Mov Disord 2006; 21: 2068-2072 (Pubitemid 46140413)
45. Pontone G, Williams JR, Bassett SS, Marsh L. Clinical features associated with impulse control disorders in Parkinson disease. Neurology 2006; 67: 1258-1261 (Pubitemid 44563839)
46. Black KJ, Friedman JH. Repetitive and impulsive behaviors in treated Parkinson disease. Neurology 2006; 67: 1118-1119 (Pubitemid 44563814)
47. Voon V, Hassan K, Zurowski M, Duff-Canning S, De Souza M, Fox S, et al. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology 2006; 66: 1750-1752 (Pubitemid 43964638)
48. Imamura A, Uitti RJ, Wszolek ZK. Dopamine agonist therapy for Parkinson disease and pathological gambling. Parkinsonism Relat Disord 2006; 12: 506-508 (Pubitemid 44793108)
49. Grosset KA, Macphee G, Pal G, Stewart D, Watt A, Davie J, et al. Problematic gambling on dopamine agonists: not such a rarity. Mov Disord 2006; 21: 2206-2208 (Pubitemid 46140438)
50. Weintraub D, Potenza MN. Impulse control disorders in Parkinson's disease. Curr Neurol Neurosci Rep 2006; 6: 302-306 (Pubitemid 44069969)
51. Pagonabarraga J, García-Sánchez C, Llebaria G, Pascual-Sedano B, Gironell A, Kulisevsky J. Controlled study of decision-making and cognitive impairment in Parkinson's disease. Mov Disord 2007; 22: 1430-1435 (Pubitemid 47280628)
52. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, et al. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Arch Neurol 2006; 63: 969-973 (Pubitemid 44036299)
53. Drapier D, Drapier S, Sauleau P, Derkinderen P, Damier P, Allain H, et al. Pathological gambling secondary to dopaminergic therapy in Parkinson's disease. Psychiatry Res 2006; 144: 241-244 (Pubitemid 44666181)
54. Healy DG. Did Géricault's 'madwoman obsessed with gambling' have Parkinson's disease? Mov Disord 2007; 22: 1069-1070
55. O'Sullivan SS, Lees AJ. Pathological gambling in Parkinson's disease. Lancet Neurol 2007; 6: 384-386
56. Morgan JC, Iyer SS, Sethi KD. Impulse control disorders and dopaminergic drugs. Arch Neurol 2006; 63: 298-299 (Pubitemid 43261750)
57. Tippmann-Peikert M, Park JG, Boeve BF, Shepard JW, Silber MH. Pathologic gambling in patients with restless legs syndrome treated with dopaminergic agonists. Neurology 2007; 68: 301-303 (Pubitemid 46148346)
58. Voon V, Thomsen T, Miyasaki JM, De Souza M, Shafro A, Fox SH, et al. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease. Arch Neurol 2007; 64: 212-216 (Pubitemid 46256561)
59. Bandini F, Primavera A, Pizzorno M, Cocito L. Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease. Parkinsonism Relat Disord 2007; 13: 369-371 (Pubitemid 47212785)
60. Ardouin C, Voon V, Worbe Y, Abouazar N, Czernecki V, Hosseini H, et al. Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation. Mov Disord 2006; 21: 1941-1946 (Pubitemid 44848942)
61. Smeding HM, Goudriaan AE, Foncke EM, Schuurman PR, Speelman JD, Schmand B. Pathological gambling after bilateral subthalamic nucleus stimulation in Parkinson disease. J Neurol Neurosurg Psychiatry 2007; 78: 517-519 (Pubitemid 46662902)
62. Ferreri F, Agbokou C, Gauthier S. Recognition and management of neuropsychiatric complications in Parkinson's disease. CMAJ 2006; 175: 1545-1552 (Pubitemid 44955118)
63. Avanzi M, Uber E, Bonfà F. Pathological gambling in two patients on dopamine replacement therapy for Parkinson's disease. Neurol Sci 2004; 25: 98-101. (Pubitemid 38923550)
64. Antonini A. Continuous dopaminergic stimulation -from theory to clinical practice. Parkinsonism Relat Disord 2007; 13 : S24-8. (Pubitemid 47454560)
65. Wong SH, Cowen Z, Allen EA, Newman PK. Internet gambling and other pathological gambling in Parkinson's disease: a case series. Mov Disord 2007; 22: 591-593 (Pubitemid 46608169)
66. Larner AJ. Medical hazards of the internet: gambling in Parkinson's disease. Mov Disord 2006; 21: 1789. (Pubitemid 44742226)
67. Saiz J, Montes JM. Trastorno obsesivo-compulsivo y trastornos del control de los impulsos. In Vallejo J, Berrios GE, eds. Estados obsesivos. Barcelona: Masson; 2006. p. 635-650
68. Lu C, Bharmal A, Suchowersky O. Gambling and Parkinson disease. Arch Neurol 2006; 63: 298.